---
figid: PMC7579731__WJGO-12-1080-g001
figlink: pmc/articles/PMC7579731/figure/F1/
number: F1
caption: 'Activation of the mitogen-activated protein kinase (RAS-RAF-mitogen-activated
  protein kinase kinase-extracellular signal-regulated kinase) pathway due to BRAF
  V600 mutations and current targeted therapy options for metastatic colorectal cancer
  patients bearing these mutations. A: In healthy cells, a growth factor binds to
  and activates receptor tyrosine kinases on the cell membrane, inducing their dimerization.
  Then, the Grb2/Sos complex is recruited to the membrane to initiate RAS activation.
  Activated RAS triggers dimerization (i.e., BRAF-BRAF or BRAF-CRAF) and activation
  of RAF proteins. RAF proteins activate the mitogen-activated protein kinase kinase-extracellular
  signal-regulated kinase (MEK-ERK) pathway to promote cell proliferation and survival;
  and B: In colorectal cancer cells bearing a BRAF V600 mutation, mutant BRAF proteins
  can signal as a monomer and potently activate the MEK-ERK pathway in a RAS independent
  manner, which accelerates tumor formation and progression. Drugs targeting BRAF
  (BRAF inhibitor) and MEK (MEK inhibitor) are currently used in the treatment of
  BRAF-mutant metastatic colorectal cancer (mCRC). The use of BRAF inhibitors suppresses
  the negative feedback from ERK to the epidermal growth factor receptor, resulting
  in the mitogen-activated protein kinase reactivation and the treatment resistance.
  Triplet inhibition of epidermal growth factor receptor, BRAF, and MEK is an emerging
  therapeutic approach for patients with BRAF-mutant mCRC. Crosstalk between the mitogen-activated
  protein kinase pathway and the PI3K and Wnt pathways can play a role in the survival
  of BRAF-mutant CRC cells and their resistance to BRAF inhibition. The PI3K and Wnt
  inhibitors may be part of the future treatment of BRAF-mutant mCRC.'
pmcid: PMC7579731
papertitle: Contemporary treatment approaches for metastatic colorectal cancer driven
  by BRAF V600 mutations.
reftext: Ozkan Kanat, et al. World J Gastrointest Oncol. 2020 Oct 15;12(10):1080-1090.
pmc_ranked_result_index: '74392'
pathway_score: 0.9668501
filename: WJGO-12-1080-g001.jpg
figtitle: Contemporary treatment approaches for metastatic colorectal cancer driven
  by BRAF V600 mutations
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7579731__WJGO-12-1080-g001.html
  '@type': Dataset
  description: 'Activation of the mitogen-activated protein kinase (RAS-RAF-mitogen-activated
    protein kinase kinase-extracellular signal-regulated kinase) pathway due to BRAF
    V600 mutations and current targeted therapy options for metastatic colorectal
    cancer patients bearing these mutations. A: In healthy cells, a growth factor
    binds to and activates receptor tyrosine kinases on the cell membrane, inducing
    their dimerization. Then, the Grb2/Sos complex is recruited to the membrane to
    initiate RAS activation. Activated RAS triggers dimerization (i.e., BRAF-BRAF
    or BRAF-CRAF) and activation of RAF proteins. RAF proteins activate the mitogen-activated
    protein kinase kinase-extracellular signal-regulated kinase (MEK-ERK) pathway
    to promote cell proliferation and survival; and B: In colorectal cancer cells
    bearing a BRAF V600 mutation, mutant BRAF proteins can signal as a monomer and
    potently activate the MEK-ERK pathway in a RAS independent manner, which accelerates
    tumor formation and progression. Drugs targeting BRAF (BRAF inhibitor) and MEK
    (MEK inhibitor) are currently used in the treatment of BRAF-mutant metastatic
    colorectal cancer (mCRC). The use of BRAF inhibitors suppresses the negative feedback
    from ERK to the epidermal growth factor receptor, resulting in the mitogen-activated
    protein kinase reactivation and the treatment resistance. Triplet inhibition of
    epidermal growth factor receptor, BRAF, and MEK is an emerging therapeutic approach
    for patients with BRAF-mutant mCRC. Crosstalk between the mitogen-activated protein
    kinase pathway and the PI3K and Wnt pathways can play a role in the survival of
    BRAF-mutant CRC cells and their resistance to BRAF inhibition. The PI3K and Wnt
    inhibitors may be part of the future treatment of BRAF-mutant mCRC.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT5A
  - WNT6
  - WNT7A
  - WNT8A
  - WNT8B
  - WNT10B
  - WNT2B
  - WNT16
  - WNT2
  - WNT3
  - WNT7B
  - WNT11
  - WNT9A
  - WNT9B
  - WNT4
  - WNT10A
  - WNT5B
  - WNT3A
  - FZD5
  - FZD7
  - FZD9
  - FZD2
  - FZD3
  - FZD1
  - FZD4
  - FZD6
  - FZD8
  - FZD10
  - EGFR
  - GRB2
  - SOS1
  - SOS2
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AXIN1
  - AXIN2
  - BRAF
  - GSK3B
  - APC
  - RAF1
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - MTOR
  - CTNNB1
  - MAPK3
  - MAPK1
  - Vemurafenib
  - dabrafenib
  - encorafenib
  - Trametinib
  - binimetinib
genes:
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Аxin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Аxin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: АРС
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CRAF
  symbol: CRAF
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: МЕКР
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕКР
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: BRAF-mutant
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals:
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: dabrafenib
  source: MESH
  identifier: C561627
- word: encorafenib
  source: ''
  identifier: ''
- word: Trametinib
  source: MESH
  identifier: C560077
- word: binimetinib
  source: MESH
  identifier: C581313
diseases: []
figid_alias: PMC7579731__F1
redirect_from: /figures/PMC7579731__F1
figtype: Figure
---
